Chambal Fertilisers Shares Rise 5% Despite Mixed Q2 Results with 41% PAT Growth
Team FS
07/Nov/2024

What's Covered Under the Article
- Chambal Fertilisers reported a 41% increase in PAT, though revenue declined by 19% due to lower P&K fertiliser volumes.
- The company's EBITDA rose by 28%, with EBITDA margins improving by 680 basis points, driven by energy efficiency and urea production.
- Chambal Fertilisers shares surged 5% on BSE, outperforming the broader market despite mixed quarterly results.
On November 7, Chambal Fertilisers and Chemicals Ltd. saw a 5.4% surge in share price to reach an intraday high of ₹530.85 on the Bombay Stock Exchange (BSE), despite reporting mixed results for the second quarter of fiscal year 2025 (Q2FY25). At approximately 11:09 AM, the stock was trading at ₹528.5, marking a 4.92% gain even as the BSE Sensex dipped by 0.99%. Chambal Fertilisers, a key player in India's agricultural sector, reported robust growth in net profit, although revenue faced a decline.
The company's market capitalisation stands at ₹21,174.47 crore, with a 52-week high of ₹575 per share and a 52-week low of ₹292.05 per share on the BSE. Over the past year, Chambal Fertilisers shares have gained 74%, far outperforming the 24% rise in the Sensex.
Key Financial Highlights of Chambal Fertilisers Q2FY25 Results
Chambal Fertilisers reported a 41% year-on-year (YoY) increase in consolidated net profit (PAT), which stood at ₹536.36 crore for Q2FY25 compared to ₹381 crore in the same quarter last year. This significant profit growth was driven by increased energy efficiency, higher production, and improved sales of Urea, the company's primary product.
EBITDA and Margins: Earnings before interest, tax, depreciation, and amortisation (EBITDA) rose by 28% YoY to ₹790 crore, compared to ₹615 crore in Q2FY24. EBITDA margins also improved, gaining 680 basis points from 11.4% to 18.2% this quarter. This margin growth is attributed to increased production and sales of Urea, as well as higher efficiency across production facilities.
Revenue Decline: Despite profit growth, the company posted a 19% decline in consolidated revenue, which fell to ₹4,346 crore from ₹5,386 crore in the same period last year. This decline is mainly due to reduced volumes of phosphatic and potassic (P&K) fertilisers, which impacted overall revenue.
The revenue contraction highlights the challenges Chambal Fertilisers faced in balancing Urea and P&K fertiliser demand, where Urea sales were strong, but P&K sales lagged due to various external factors affecting agricultural input requirements.
Operational Factors Behind the Growth
Chambal Fertilisers has maintained strong operational efficiency, especially in energy usage, which contributed to the improved profit margins. The company’s focus on energy efficiency not only reduced costs but also helped mitigate some of the revenue challenges by enhancing production quality and quantity. Higher production volumes and favourable margins in certain product classifications, including central product classification and soil nitrogen, further contributed to the company’s growth.
About Chambal Fertilisers and Chemicals Ltd.
Chambal Fertilisers and Chemicals, founded in 1985 and headquartered in Kota, Rajasthan, is a significant entity in India’s agricultural sector. It primarily manufactures Urea, a key nitrogenous fertiliser essential for Indian farming. As part of the DCM Shriram Group, the company plays a vital role in supporting India’s agrarian economy, meeting the country’s rising demand for fertilisers.
Sustainability Commitment: Chambal Fertilisers places emphasis on sustainable practices. By adhering to strict regulatory standards, the company aims to minimise its environmental impact while contributing to agricultural productivity. This commitment aligns with the rising global focus on environmentally responsible production practices.
Role in the Indian Agrarian Economy: As one of India’s leading fertiliser manufacturers, Chambal Fertilisers serves a crucial role in supporting Indian agriculture. With a significant focus on producing Urea, the company helps meet the needs of farmers across India, contributing to agricultural stability and productivity.
Market Performance and Stock Movement
The surge in Chambal Fertilisers' stock price despite mixed earnings reflects investor confidence in the company’s ability to manage profitability through operational efficiencies and product focus, even when revenue faces headwinds. This performance is particularly noteworthy as it comes against the backdrop of a broader market decline. The stock has outperformed the Sensex by a wide margin over the past year, demonstrating its resilience and the strategic advantage of its Urea-centric product line.
Outlook and Future Prospects
Looking ahead, Chambal Fertilisers is expected to continue focusing on sustainability and operational efficiency to drive growth, especially in its Urea segment, which remains central to its business. The company’s management is likely to assess strategies to balance the production and demand of P&K fertilisers to avoid further revenue drops in future quarters. Moreover, as it remains a critical player in the Indian fertiliser market, Chambal Fertilisers is positioned to benefit from ongoing demand for agricultural inputs in India’s growing economy.
Conclusion
Chambal Fertilisers' Q2FY25 results highlight its strong profitability growth amid revenue challenges. With a robust focus on energy efficiency, Urea production, and sustainable practices, the company is well-positioned to meet the needs of India’s agrarian sector while enhancing shareholder value. Its stock’s upward movement underscores investor confidence in its business fundamentals and growth potential, even as it navigates the complexities of balancing its fertiliser product portfolio.
The Upcoming IPOs in this week and coming weeks are Archit Nuwood Industries Limited, Neelam Lines and Garments, Rosmerta Digital, NTPC Green, Avanse Financial and Zinka Logistics.
The Current active IPO is Sagility India Limited, Swiggy, ACME Solar Holdings and Niva Bupa Health .
For more insights into financial trends , visit our Top News Headlines. You can also explore investment opportunities in the market and apply for upcoming IPOs through our Best IPO to Apply Now section.
Join our Trading with CA Abhay Telegram Channel for regular stock market trading and investment calls by CA Abhay Varn, a SEBI Registered Research Analyst. Stay updated with the latest in share market news and IPO updates by joining the Finance Saathi Telegram Channel.
Start your stock market journey today by opening a free demat account with Choice Broking FinX.
Related News
Disclaimer
The information provided on this website is for educational and informational purposes only and should not be considered as financial advice, investment advice, or trading recommendations.
Trading in stocks, forex, commodities, cryptocurrencies, or any other financial instruments involves high risk and may not be suitable for all investors. Prices can fluctuate rapidly, and there is a possibility of losing part or all of your invested capital.
We do not guarantee any profits, returns, or outcomes from the use of our website, services, or tools. Past performance is not indicative of future results.You are solely responsible for your investment and trading decisions. Before making any financial commitment, it is strongly recommended to consult with a qualified financial advisor or do your own research.
By accessing or using this website, you acknowledge that you have read, understood, and agree to this disclaimer. The website owners, partners, or affiliates shall not be held liable for any direct or indirect loss or damage arising from the use of information, tools, or services provided here.